文献速递骨质疏松与钙磷/甲状旁腺垂体与肾上腺疾病

甲状旁腺腺瘤离体组织分析揭示钙感知行为的替代模式

Ex Vivo Intact Tissue Analysis Reveals Alternative Calcium-sensing Behaviors in Parathyroid Adenomas.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该研究对39例原发性甲状旁腺功能亢进症(PHPT)手术患者的甲状旁腺腺瘤进行离体组织检测,依据钙剂量-反应曲线将肿瘤分为3种功能类型。钙敏感性减低的肿瘤最常见(18/39),且与骨密度降低显著相关(P=0.0009);无钙感知缺陷的肿瘤(11/39)与术前PTH较高相关(P=0.036)。研究提示钙感知能力在甲状旁腺肿瘤间存在差异,CASR下调并非必然机制。

要点

  • 甲状旁腺腺瘤按钙敏感性可分为3种功能类型。
  • 钙敏感性减低的肿瘤与骨密度降低显著相关(P=0.0009)。
  • CASR下调并非钙感知失败的必然机制。

核心结论

  • 甲状旁腺肿瘤的钙感知能力存在差异,CASR下调并非钙感知失败的必然机制。
  • 肿瘤钙反应性的差异可能 contribute 于PHPT临床表现的变异。

研究设计与样本

  • 研究纳入39例在大型公立大学医院内分泌外科转诊中心接受手术的PHPT患者,评估术前临床数据与甲状旁腺肿瘤生化行为的相关性。
  • 采用离体完整组织 interrogative 检测,比较甲状旁腺腺瘤与正常供体腺体的钙感知能力。
  • 根据钙剂量-反应曲线对肿瘤进行功能分类,并比较各类别的临床参数。

主要发现

  • 甲状旁腺腺瘤可分为3种不同的功能类型。
  • 钙敏感性减低的肿瘤最常见(18/39),且与骨密度降低显著相关(P=0.0009)。
  • 无钙感知缺陷的肿瘤(11/39)与术前PTH较高相关(P=0.036)。
  • 第三组(6/39)显示非S形钙/PTH反应曲线,其中4/6肿瘤表达RCAN1升高。

临床怎么用

  • 甲状旁腺腺瘤的钙感知功能分型可能有助于解释PHPT患者的临床异质性。
  • 对于钙敏感性减低的肿瘤患者,应关注骨密度降低的风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The biochemical basis for clinical variability in primary hyperparathyroidism (PHPT) is poorly understood. OBJECTIVE: This study aimed to define parathyroid tumor biochemical properties associated with calcium-sensing failure in PHPT patients, and to relate differences in these profiles to variations in clinical presentation. METHODS: Preoperative clinical data from a sequential series of 39 patients undergoing surgery for PHPT at an endocrine surgery referral center in a large, public university hospital were evaluated for correlation to parathyroid tumor biochemical behavior. An intact tissue, ex vivo interrogative assay was employed to evaluate the calcium-sensing capacity of parathyroid adenomas relative to normal donor glands. Tumors were functionally classified based on calcium dose-response curve profiles, and clinical parameters were compared among the respective classes. Changes in the relative expression of 3 key components in the calcium/parathyroid hormone (PTH) signaling axis-CASR, RGS5, and RCAN1-were evaluated as potential mechanisms for calcium-sensing failure. RESULTS: Parathyroid adenomas grouped into 3 distinct functional classes. Tumors with diminished calcium sensitivity were the most common (18 of 39) and were strongly associated with reduced bone mineral density (P = 0.0009). Tumors with no calcium-sensing deficit (11 of 39) were associated with higher preoperative PTH (P = 0.036). A third group (6/39) displayed a nonsigmoid calcium/PTH response curve; 4 of these 6 tumors expressed elevated RCAN1. CONCLUSION: Calcium-sensing capacity varies among parathyroid tumors but downregulation of the calcium-sensing receptor (CASR) is not an obligate underlying mechanism. Differences in tumor calcium responsiveness may contribute to variations in PHPT clinical presentation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Koh J, Zhang R, Roman S, et al. Ex Vivo Intact Tissue Analysis Reveals Alternative Calcium-sensing Behaviors in Parathyroid Adenomas. J Clin Endocrinol Metab. 2021. PMID: 34272844. doi:10.1210/clinem/dgab524

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。